Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Fixed-Dose Study of AGN-241751 in Adult Participants With Major Depressive Disorder

NCT03586427 is registered in ClinicalTrials.gov with Syndeio Biosciences, Inc as lead sponsor.

NCT NCT03586427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03586427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Fixed-Dose Study of AGN-241751 in Adult Participants With Major Depressive Disorder
Lead sponsor
Syndeio Biosciences, Inc
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2018
Completion date
August 21, 2019
Enrollment
251 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major